Directorate Change

Physiomics plc ("Physiomics" or "the Company")

 

Resignation of Chief Executive Officer

 

 

Oxford, UK 8 June 2006: The Board of Physiomics plc (AIM:PYC), a European
systems biology simulation company, today announces that Dr John Savin, CEO has
left the Company and resigned as a Director.

Mr David Evans, Chairman of Physiomics commented:

"The need to secure a long term future for the Company on a basis different
from the current business model has required a detailed strategic review in
conjunction with EiRx Pharma Ltd which currently controls a 69% shareholding.
Dr Savin felt that this process would be easier if he were to leave the Company
on amicable terms and this has now been agreed. On behalf of the Board, I would
like to thank Dr Savin for his pivotal contribution to the development of
Physiomics since 2001."

Dr Savin commented

"I am very sad to be leaving Physiomics having led the business from its
start-up phase through the AIM listing and for its first 18 months as a quoted
company. However, I am pleased that the Company is now well placed to take
advantage of the increasing opportunities in the application of system
biology."


Contact:
David Evans, Chairman
07740 084452